Rhode Island General Laws
Chapter 5-19.1 - Pharmacies
Section 5-19.1-32. - Limited-function tests.

§ 5-19.1-32. Limited-function tests.
(a) Upon receiving consent from the patient, a pharmacist performing a limited-function test in accordance with this chapter shall report test results to the patient’s primary care practitioner, if known, within a reasonable period of time. In the event that a patient with an abnormal test result does not have an existing relationship with a primary care practitioner, the pharmacist shall make efforts to refer the patient to a primary care practitioner, practice, health center, or clinic.
(b)(1) The pharmacy shall develop policies and procedures for emergency situations related to the provision of limited-function health tests, to include the prompt reporting of test results to a patient’s primary care practitioner, if known.
(2) The department shall promulgate rules and regulations to carry out the provisions of this section. The department’s rules and regulations may include the following:
(i) Requirements for the pharmacist to inform the patient that the limited-function test results are intended for informational and educational purposes, rather than diagnostic purposes; and
(ii) Requirements ensuring appropriate temperature and environmental controls to maintain the efficacy of the limited-function test kit.
History of Section.P.L. 2015, ch. 157, § 3; P.L. 2015, ch. 182, § 3.

Structure Rhode Island General Laws

Rhode Island General Laws

Title 5 - Businesses and Professions

Chapter 5-19.1 - Pharmacies

Section 5-19.1-1. - Introduction.

Section 5-19.1-2. - Definitions.

Section 5-19.1-3. - State board of pharmacy — Creation — Membership — Oath — Vacancies.

Section 5-19.1-4. - State board of pharmacy — Meetings — Quorum — Chairperson.

Section 5-19.1-5. - State board of pharmacy — Powers and duties.

Section 5-19.1-6. - Board of pharmacy — Inspectors and assistants.

Section 5-19.1-7. - Director of health — Powers and duties.

Section 5-19.1-8. - Licensing required.

Section 5-19.1-9. - Pharmacy license — Fee — Display — Declaration of ownership and location.

Section 5-19.1-10. - Restricted pharmacies — License.

Section 5-19.1-11. - Nonresident pharmacy — Fees — Display — Declaration of ownership and location.

Section 5-19.1-11.1. - Rules.

Section 5-19.1-12. - Manufacturer’s license — Fees — Display — Declaration of ownership and location.

Section 5-19.1-13. - Wholesaler’s license — Fees — Display — Declaration of ownership and location.

Section 5-19.1-14. - Licensing of pharmacists — Prerequisites — Examinations — Reciprocity — Fees — Renewal.

Section 5-19.1-15. - Pharmacy interns — License — Fees — Renewals.

Section 5-19.1-16. - Pharmacy technicians — License — Fees — Renewals.

Section 5-19.1-17. - Central database — Operation.

Section 5-19.1-18. - Necessity of prescription label.

Section 5-19.1-19. - Pharmacists — Substitution of drugs.

Section 5-19.1-19.1. - Pharmacists — Substitution of biological products.

Section 5-19.1-20. - License — Renewal — Fee display.

Section 5-19.1-21. - Refusal, suspension and revocation of licensees.

Section 5-19.1-22. - Authorized practices.

Section 5-19.1-23. - Unlawful practices.

Section 5-19.1-24. - Emergency prescription refill.

Section 5-19.1-25. - Immunity.

Section 5-19.1-26. - Refusal, suspension, and revocation of licenses — Appeal procedure.

Section 5-19.1-27. - Penalty for operating without license.

Section 5-19.1-28. - Severability.

Section 5-19.1-29. - Continuity of administration.

Section 5-19.1-30. - List of drugs to be posted — Display of current selling price required — Exception.

Section 5-19.1-31. - Administration of influenza immunizations to individuals between the ages of nine (9) years and eighteen (18) years, inclusive.

Section 5-19.1-32. - Limited-function tests.

Section 5-19.1-33. - Partial fill of Schedule II controlled substance.

Section 5-19.1-34. - Notice of warning regarding use of Schedule II controlled substances to be posted.

Section 5-19.1-35. - Audits.